Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies
- 1 October 1983
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 75 (4), 95-102
- https://doi.org/10.1016/0002-9343(83)90141-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Role of labetalol in acute myocardial infarction.British Journal of Clinical Pharmacology, 1982
- DIRECT VASODILATATION BY LABETALOL IN ANAESTHETIZED DOGSBritish Journal of Pharmacology, 1980
- Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.Published by Wiley ,1979
- Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.Published by Wiley ,1979
- Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.Published by Wiley ,1979
- Labetalol in the treatment of patients with hypertension and renal function impairment.British Journal of Clinical Pharmacology, 1979
- Labetalol infusion in acute myocardial infarction with systemic hypertension.Published by Wiley ,1979
- Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.Circulation, 1977
- Relationship between plasma concentrations and pharmacological effects of labetalolEuropean Journal of Clinical Pharmacology, 1977
- Pharmacological basis for antihypertensive effects of intravenous labetalol.Heart, 1977